s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
4
Ho Maykin: Statement of changes in beneficial ownership of securities
Filed
Monday, September 18, 2023
Period
Sep 14, 2023
Accession number
0001610717-23-000281
Documents
form4.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header